Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Kostrzewa

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Neurotoxicity Research|January 16, 2020
p-Chloroamphetamine-Enhanced Neostriatal Dopamine Exocytosis in Rats Neonatally Co-lesioned with 6-OHDA and 5,7-DHT: Relevance to Parkinson's DiseaseJohn P Kostrzewa, Richard M Kostrzewa
Neurotoxicity Research|July 2, 2003
Dopamine receptor supersensitivity: an outcome and index of neurotoxicityRichard M Kostrzewa, John P Kostrzewa, Ryszard Brus
Peptides|July 21, 2015
Botulinum neurotoxin: Progress in negating its neurotoxicity; and in extending its therapeutic utility via molecular engineering. MiniReviewRichard M Kostrzewa, Rose Anna Kostrzewa, John P Kostrzewa
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|March 20, 2010
Radiofrequency coblation decreases blood loss during endoscopic sinonasal and skull base tumor removalJohn P Kostrzewa, Jumin Sunde, Kristen O Riley, et al.
Current Topics in Behavioral Neurosciences|October 18, 2015
Perinatal 6-Hydroxydopamine to Produce a Lifelong Model of Severe Parkinson's DiseaseJohn P Kostrzewa, Rose Anna Kostrzewa, Richard M Kostrzewa, et al.
Neurotoxicity Research|January 11, 2005
Dopamine D2 agonist priming in intact and dopamine-lesioned ratsRichard M Kostrzewa, John P Kostrzewa, Przemyslaw Nowak, et al.
Neurotoxicity Research|December 17, 2008
Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicabilityRichard M Kostrzewa, John P Kostrzewa, Russell W Brown, et al.
Neurotoxicity Research|January 13, 2004
Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned ratsRyszard Brus, Richard M Kostrzewa, Przemysław Nowak, et al.
Neurotoxicity Research|April 24, 2007
Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatmentRichard M Kostrzewa, Nuo-Yu Huang, John P Kostrzewa, et al.
Current Topics in Behavioral Neurosciences|October 18, 2015
Perinatal 6-Hydroxydopamine Modeling of ADHDJohn P Kostrzewa, Rose Anna Kostrzewa, Richard M Kostrzewa, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neurotoxicity Research|January 16, 2020
p-Chloroamphetamine-Enhanced Neostriatal Dopamine Exocytosis in Rats Neonatally Co-lesioned with 6-OHDA and 5,7-DHT: Relevance to Parkinson's DiseaseJohn P Kostrzewa, Richard M Kostrzewa
Neurotoxicity Research|July 2, 2003
Dopamine receptor supersensitivity: an outcome and index of neurotoxicityRichard M Kostrzewa, John P Kostrzewa, Ryszard Brus
Peptides|July 21, 2015
Botulinum neurotoxin: Progress in negating its neurotoxicity; and in extending its therapeutic utility via molecular engineering. MiniReviewRichard M Kostrzewa, Rose Anna Kostrzewa, John P Kostrzewa
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|March 20, 2010
Radiofrequency coblation decreases blood loss during endoscopic sinonasal and skull base tumor removalJohn P Kostrzewa, Jumin Sunde, Kristen O Riley, et al.
Current Topics in Behavioral Neurosciences|October 18, 2015
Perinatal 6-Hydroxydopamine to Produce a Lifelong Model of Severe Parkinson's DiseaseJohn P Kostrzewa, Rose Anna Kostrzewa, Richard M Kostrzewa, et al.
Neurotoxicity Research|January 11, 2005
Dopamine D2 agonist priming in intact and dopamine-lesioned ratsRichard M Kostrzewa, John P Kostrzewa, Przemyslaw Nowak, et al.
Neurotoxicity Research|December 17, 2008
Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicabilityRichard M Kostrzewa, John P Kostrzewa, Russell W Brown, et al.
Neurotoxicity Research|January 13, 2004
Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned ratsRyszard Brus, Richard M Kostrzewa, Przemysław Nowak, et al.
Neurotoxicity Research|April 24, 2007
Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatmentRichard M Kostrzewa, Nuo-Yu Huang, John P Kostrzewa, et al.
Current Topics in Behavioral Neurosciences|October 18, 2015
Perinatal 6-Hydroxydopamine Modeling of ADHDJohn P Kostrzewa, Rose Anna Kostrzewa, Richard M Kostrzewa, et al.
Pageof 2